Crossmark

Retraction Note: Sensitization of MDA-MBA231 breast cancer cell to docetaxel by myricetin loaded into biocompatible lipid nanoparticles via sub-G1 cell cycle arrest mechanism

Crossref DOI link: https://doi.org/10.1007/s00210-024-03709-0

Published Online: 2024-12-10

Published Print: 2025-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Maroufi, Nazila Fathi

Vahedian, Vahid

Mazrakhondi, Seyed Ali Miresmaeili

Kooti, Wesam

Khiavy, Hosein Ajami

Bazzaz, Roya

Ramezani, Fatemeh

Pirouzpanah, Seyed Mohammadbagher

Ghorbani, Marjan

Akbarzadeh, Maryam

Hajipour, Hamed

Ghanbarzadeh, Saeed

Sabzichi, Mehdi https://orcid.org/0000-0002-5149-1378
License Information

Text and Data Mining valid from 2024-12-10

Version of Record valid from 2024-12-10
More Information

Article History

First Online: 10 December 2024

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below